MEDICATION FOR OBSTETRIC PATIENT AND ADMINISTRATION DURING PREGNANCY FOR HYPERTENSION AND PRETERM LABOR

Our current research was led at Lahore General Hospital Lahore from December 2017 to November 2018. Personalize prescribing helps to distinguish right portion of right medicine for right case at right time. On a regular basis, the individualization of treatment depends on pharmacogenomic cosmetics of the individual and the ecological variables that adjust the attitude and reply to sedation. Despite these elements, during pregnancy, a woman's body undergoes many progressions that can affect the efficacy repairing effects of medicines. However, there is insignificant exploration concerning modified medication in obstetrics. The appropriateness of pharmacogenetic testing in obstetrical consideration is dependent on proof of scientific legitimacy, medical legitimacy, and medical usefulness. Here, authors present data at briefly about possible usefulness of personalized medication for the treatment of the obstetric patient for opioid torment, hypertension, and preterm labor, in addition discourse barriers to transporting the personalized drug to the obstetric center. Keywords: Personalized drug, Obstetrics, drugs, pharmacogenetic